• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿组织因子活性检测方法的开发与验证

Development and validation of an assay for urinary tissue factor activity.

作者信息

Lwaleed B A, Chisholm M, Francis J L

机构信息

University Department of Haematology, Southampton University Hospitals, UK.

出版信息

J Clin Pathol. 1999 Mar;52(3):219-24. doi: 10.1136/jcp.52.3.219.

DOI:10.1136/jcp.52.3.219
PMID:10450183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC501083/
Abstract

BACKGROUND

Activation of blood coagulation is a common complication of cancer and inflammation in both humans and experimental animals. Increased production of tissue factor--the principal initiator of the coagulation process--by endothelial cells, monocytes, and macrophages has been implicated in these conditions.

AIM

To investigate whether urinary tissue factor (uTF) might reflect the state of monocyte/macrophage activation and be a useful diagnostic test.

METHODS

Urine was centrifuged at 51,000 g to sediment tissue factor containing membrane vesicles. The tissue factor was then solubilised in beta-octyl-glucopyranoside and assayed in a specific chromogenic assay adapted for use in microtitre plates.

RESULTS

The assay proved to be sensitive, specific, and reproducible. The normal range of uTF was relatively narrow and unaffected by age, sex, or cigarette smoking. Levels were not significantly influenced by storage of urine samples before assay or by the presence of fresh blood in the urine sample.

CONCLUSIONS

This method may have diagnostic application in the study of haemostatic activation in patients with cancer and other disease states.

摘要

背景

血液凝固的激活是人类和实验动物癌症及炎症常见的并发症。内皮细胞、单核细胞和巨噬细胞中组织因子(凝血过程的主要启动因子)产量增加与这些情况有关。

目的

研究尿组织因子(uTF)是否能反映单核细胞/巨噬细胞的激活状态并成为一项有用的诊断检测方法。

方法

尿液在51,000g下离心,使含组织因子的膜泡沉淀。然后将组织因子溶解于β-辛基葡萄糖苷中,并在适用于微量滴定板的特定显色测定法中进行检测。

结果

该检测方法被证明具有敏感性、特异性和可重复性。uTF的正常范围相对较窄,不受年龄、性别或吸烟的影响。检测前尿液样本的储存或尿液样本中新鲜血液的存在对其水平没有显著影响。

结论

该方法可能在癌症及其他疾病状态患者止血激活的研究中具有诊断应用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc6a/501083/3becc71b6b17/jclinpath00276-0062-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc6a/501083/68af9e0623e3/jclinpath00276-0061-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc6a/501083/3becc71b6b17/jclinpath00276-0062-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc6a/501083/68af9e0623e3/jclinpath00276-0061-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc6a/501083/3becc71b6b17/jclinpath00276-0062-a.jpg

相似文献

1
Development and validation of an assay for urinary tissue factor activity.尿组织因子活性检测方法的开发与验证
J Clin Pathol. 1999 Mar;52(3):219-24. doi: 10.1136/jcp.52.3.219.
2
Tissue factor assays as diagnostic tools for cancer? Correlation between urinary and monocyte tissue factor activity.组织因子检测作为癌症的诊断工具?尿液与单核细胞组织因子活性之间的相关性。
J Hematother Stem Cell Res. 1999 Dec;8(6):659-68. doi: 10.1089/152581699319830.
3
Urinary tissue factor: a potential marker of disease.
J Pathol. 1999 May;188(1):3-8. doi: 10.1002/(SICI)1096-9896(199905)188:1<3::AID-PATH282>3.0.CO;2-T.
4
Urinary tissue factor in glomerulonephritis: a potential marker of glomerular injury?肾小球肾炎中的尿组织因子:肾小球损伤的潜在标志物?
J Clin Pathol. 1997 Apr;50(4):336-40. doi: 10.1136/jcp.50.4.336.
5
Urinary tissue factor levels in patients with breast and colorectal cancer.乳腺癌和结直肠癌患者的尿液组织因子水平。
J Pathol. 1999 Feb;187(3):291-4. doi: 10.1002/(SICI)1096-9896(199902)187:3<291::AID-PATH213>3.0.CO;2-8.
6
Urinary tissue factor levels in patients with bladder and prostate cancer.膀胱癌和前列腺癌患者的尿液组织因子水平。
Eur J Surg Oncol. 2000 Feb;26(1):44-9. doi: 10.1053/ejso.1999.0739.
7
Functional and structural properties of urinary tissue factor.尿组织因子的功能和结构特性
Nephrol Dial Transplant. 1999 Mar;14(3):588-96. doi: 10.1093/ndt/14.3.588.
8
[Urinary level of tissue factor and its procoagulant activity in patients with type 2 diabetes].2型糖尿病患者尿液中组织因子水平及其促凝活性
Nan Fang Yi Ke Da Xue Xue Bao. 2011 May;31(5):878-81.
9
Effect of kidney function and disease status on urinary tissue factor measurements.肾功能和疾病状态对尿组织因子测量的影响。
J Clin Pathol. 1998 Mar;51(3):234-7. doi: 10.1136/jcp.51.3.234.
10
Monocyte tissue factor levels in cancer patients.
Saudi Med J. 2000 Aug;21(8):722-9.

引用本文的文献

1
Effect of Freezing Time on Tissue Factor Activity and Macronutrients of Human Milk.冻存时间对人乳组织因子活性和宏量营养素的影响。
Protein J. 2020 Oct;39(5):591-597. doi: 10.1007/s10930-020-09916-x. Epub 2020 Sep 28.
2
Determination of storage time of saliva samples obtained from patients with and without chronic periodontitis for the comparison of some biochemical and cytological parameters.比较慢性牙周炎患者和非慢性牙周炎患者唾液样本的一些生化和细胞学参数,确定唾液样本的储存时间。
J Clin Lab Anal. 2013 Jul;27(4):261-6. doi: 10.1002/jcla.21592.
3
Kidney function and multiple hemostatic markers: cross sectional associations in the multi-ethnic study of atherosclerosis.

本文引用的文献

1
Cord blood clotting factors in neonates of smoking and non-smoking mothers.吸烟与不吸烟母亲的新生儿的脐血凝血因子
Int J Clin Lab Res. 1994;24(3):177-9. doi: 10.1007/BF02592450.
2
Urinary tissue factor levels in prostatic carcinoma: a potential marker of metastatic spread?前列腺癌患者尿液组织因子水平:转移扩散的潜在标志物?
Br J Urol. 1993 May;71(5):587-92. doi: 10.1111/j.1464-410x.1993.tb16030.x.
3
Lipid activation of coagulation factor III apoprotein (tissue factor)--reconstitution of the protein-membrane complex.凝血因子III载脂蛋白(组织因子)的脂质激活——蛋白质-膜复合物的重构
肾功能和多种止血标志物:动脉粥样硬化多民族研究中的横断面关联。
BMC Nephrol. 2011 Jan 26;12:3. doi: 10.1186/1471-2369-12-3.
Thromb Haemost. 1980 Aug 29;44(1):12-5.
4
Thromboplastin activity of mouse peritoneal macrophages.
Thromb Res. 1981;24(1-2):61-71. doi: 10.1016/0049-3848(81)90032-3.
5
Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues.单核吞噬细胞产生促凝血活性:一种可能导致恶性组织内凝血激活的机制。
Blood. 1983 Aug;62(2):271-3.
6
Abnormalities of blood coagulation in patients with cancer. Fibrinopeptide A generation and tumor growth.癌症患者的血液凝固异常。纤维蛋白肽A的生成与肿瘤生长。
Cancer. 1983 Jan 15;51(2):301-7. doi: 10.1002/1097-0142(19830115)51:2<301::aid-cncr2820510223>3.0.co;2-7.
7
Identification of the plasminogen activator(s) produced by the transformed liver cell line, SK-HEP-1.转化的肝癌细胞系SK-HEP-1所产生的纤溶酶原激活物的鉴定。
Thromb Res. 1983 Oct 1;32(1):29-34. doi: 10.1016/0049-3848(83)90151-2.
8
The procoagulant in human urine: purification, assay and some biochemical and physiological properties.人尿中的促凝剂:纯化、测定及某些生化和生理特性
Thromb Diath Haemorrh. 1966 Dec 1;16(3):586-605.
9
Procoagulant content of human urine in health and disease.健康与疾病状态下人体尿液中的促凝物质含量。
Am J Clin Pathol. 1968 Aug;50(2):198-210. doi: 10.1093/ajcp/50.2.198.
10
Urinary procoagulant excretion and its relation to kidney function.尿促凝物质排泄及其与肾功能的关系。
Nephron. 1970;7(2):165-77. doi: 10.1159/000179818.